receptorbind
domain
rbd
sar
coronaviru
sarscov
spike
protein
contain
multipl
conformationdepend
epitop
induc
neutral
antibodi
respons
use
cell
establish
cell
line
stabl
express
residu
rbd
determin
antigen
immunogen
found
react
strongli
panel
six
monoclon
antibodi
recogn
variou
conform
linear
epitop
rbd
suggest
recombin
protein
maintain
intact
conform
good
antigen
immun
mice
result
induct
high
titer
rbdspecif
neutral
antibodi
potent
cell
respons
induc
immun
protect
major
vaccin
mice
sarscov
challeng
result
suggest
recombin
rbd
produc
establish
stabl
cell
line
maintain
strong
immunogen
high
potenti
use
effect
econom
subunit
sar
vaccin
elsevi
inc
right
reserv
global
outbreak
sever
acut
respiratori
syndrom
sar
led
sever
health
econom
consequ
worldwid
prevent
reemerg
infecti
diseas
potenti
anim
reservoir
necessari
develop
effect
vaccin
antivir
agent
sar
coronaviru
sarscov
caus
agent
sar
compar
antivir
strategi
vaccin
particularli
base
spike
protein
demonstr
greater
efficaci
prevent
sar
receptorbind
domain
rbd
protein
contain
multipl
conformationaldepend
epitop
induc
potent
neutral
antibodi
sarscov
infect
suggest
attract
target
develop
sar
vaccin
therefor
establish
approach
produc
larg
quantiti
recombin
rbd
appropri
antigen
immunogen
need
chines
hamster
ovari
cho
cell
line
wide
use
express
recombin
protein
biopharmaceut
product
stabl
largescal
manner
select
stabl
cell
line
establish
express
persist
recombin
secret
protein
dust
mite
allergen
blo
human
mucin
transform
growth
factorb
tgfb
furthermor
adapt
serumfre
medium
recombin
protein
highli
express
suspens
cultur
make
possibl
purifi
protein
suspens
larg
quantiti
protein
obtain
way
shown
maintain
biolog
activ
proper
conform
therefor
success
express
purif
number
recombin
protein
cell
provid
ration
basi
develop
effect
econom
subunit
sar
vaccin
continu
product
recombin
protein
contain
function
domain
sarscov
protein
base
reason
present
studi
aim
express
residu
recombin
rbd
sarscov
protein
establish
stabl
cell
line
determin
antigen
immunogen
protect
immun
mous
model
plasmid
construct
protein
transient
express
purif
gene
encod
acid
residu
rbd
sarscov
protein
amplifi
pcr
use
plasmid
contain
codonoptim
fulllength
protein
templat
follow
insert
gs
gene
express
vector
recombin
rbd
plasmid
transient
transfect
use
fugen
transfect
reagent
roch
appli
scienc
indianapoli
cell
atcc
manassa
va
transfect
medium
atcc
replac
fresh
optimem
reducedserum
medium
invitrogen
carlsbad
ca
h
see
front
matter
receptorbind
domain
rbd
sar
coronaviru
sarscov
spike
protein
contain
multipl
conformationdepend
epitop
induc
neutral
antibodi
respons
use
cell
establish
cell
line
stabl
express
residu
rbd
determin
antigen
immunogen
found
react
strongli
panel
six
monoclon
antibodi
recogn
variou
conform
linear
epitop
rbd
suggest
recombin
protein
maintain
intact
conform
good
antigen
immun
mice
result
induct
high
titer
rbdspecif
neutral
antibodi
potent
cell
respons
induc
immun
protect
major
vaccin
mice
sarscov
challeng
result
suggest
recombin
rbd
produc
establish
stabl
cell
line
maintain
strong
immunogen
high
potenti
use
effect
econom
subunit
sar
vaccin
elsevi
inc
right
reserv
global
outbreak
sever
acut
respiratori
syndrom
sar
led
sever
health
econom
consequ
worldwid
prevent
reemerg
infecti
diseas
potenti
anim
reservoir
necessari
develop
effect
vaccin
antivir
agent
sar
coronaviru
sarscov
caus
agent
sar
compar
antivir
strategi
vaccin
particularli
base
spike
protein
demonstr
greater
efficaci
prevent
sar
receptorbind
domain
rbd
protein
contain
multipl
conformationaldepend
epitop
induc
potent
neutral
antibodi
sarscov
infect
suggest
attract
target
develop
sar
vaccin
therefor
establish
approach
produc
larg
quantiti
recombin
rbd
appropri
antigen
immunogen
need
chines
hamster
ovari
cho
cell
line
wide
use
express
recombin
protein
biopharmaceut
product
stabl
largescal
manner
select
stabl
cell
line
establish
express
persist
recombin
secret
protein
dust
mite
allergen
blo
human
mucin
transform
growth
factorb
tgfb
furthermor
adapt
serumfre
medium
recombin
protein
highli
express
suspens
cultur
make
possibl
purifi
protein
suspens
larg
quantiti
protein
obtain
way
shown
maintain
biolog
activ
proper
conform
therefor
success
express
purif
number
recombin
protein
cell
provid
ration
basi
develop
effect
econom
subunit
sar
vaccin
continu
product
recombin
protein
contain
function
domain
sarscov
protein
base
reason
present
studi
aim
express
residu
recombin
rbd
sarscov
protein
establish
stabl
cell
line
determin
antigen
immunogen
protect
immun
mous
model
plasmid
construct
protein
transient
express
purif
gene
encod
acid
residu
rbd
sarscov
protein
amplifi
pcr
use
plasmid
contain
codonoptim
fulllength
protein
templat
follow
insert
gs
gene
express
vector
recombin
rbd
plasmid
transient
transfect
use
fection
cultur
supernat
collect
h
later
follow
purifi
recombin
protein
use
column
promega
madison
wi
accord
manufactur
protocol
purifi
protein
design
establish
stabl
cell
line
express
protein
recombin
rbd
plasmid
transfect
cell
twentyfour
hour
later
cultur
medium
chang
fresh
glutaminefre
dmem
safc
bioscienc
lenexa
ks
contain
dialyz
fb
dfb
invitrogen
glutamin
synthetas
gs
supplement
safc
bioscienc
lm
lmethionin
sulfoximin
msx
select
agent
chemicon
billerica
fresh
select
medium
replac
everi
day
thereaft
appear
resist
coloni
pick
expand
cultur
protein
express
detect
western
blot
elisa
establish
stabl
cell
line
express
protein
adapt
cho
serumfre
medium
accord
manufactur
protocol
safc
bioscienc
facilit
largescal
recombin
protein
express
purif
rbd
protein
perform
use
condit
suspens
cultur
medium
western
blot
purifi
protein
test
express
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
accord
protocol
previous
describ
blot
detect
panel
rbdspecif
monoclon
antibodi
mab
gener
laboratori
final
concentr
lgml
mous
vaccin
sampl
collect
five
femal
balbc
mice
subcutan
sc
vaccin
protein
accord
protocol
previous
describ
lgmous
purifi
protein
contain
freund
complet
adjuv
fca
sigma
prime
lgmous
immunogen
contain
freund
incomplet
adjuv
fia
sigma
two
subsequ
boost
interv
pb
use
neg
control
ten
day
postlast
vaccin
mous
sera
collect
assay
detect
specif
igg
neutral
antibodi
respons
splenocyt
assay
determin
cellular
respons
ten
day
postlast
vaccin
mice
also
challeng
live
sarscov
day
postchalleng
detect
viral
replic
perform
elisa
previous
describ
elisa
protocol
use
select
cell
stabli
express
protein
detect
rbdspecif
igg
antibodi
proteinvaccin
mous
sera
protein
express
detect
microtit
plate
precoat
cell
cultur
supernat
sarscov
rbdspecif
mab
dilut
ad
wash
pbst
sera
igg
antibodi
detect
plate
first
coat
express
protein
follow
addit
serial
dilut
mous
sera
wash
detect
conduct
neutral
assay
neutral
assay
sar
pseudoviru
infect
perform
accord
method
establish
laboratori
ie
use
cell
express
receptor
angiotensinconvert
enzym
neutral
sar
pseudoviru
calcul
indic
neutral
antibodi
titer
nt
neutral
assay
live
sarscov
strain
genbank
access
infect
perform
previous
describ
neutral
titer
complet
prevent
cytopath
effect
cpe
well
nt
calcul
reedmuench
method
elispot
assay
assay
perform
use
elispot
mous
kit
mabtech
mariemont
oh
accord
manufactur
protocol
previous
describ
method
ninetysixwel
elispot
plate
coat
antiifnc
mab
cell
incub
h
presenc
identifi
restrict
sarscovspecif
cytotox
lymphocyt
ctl
peptid
kcygvsatkl
th
peptid
nynykyrylr
plate
incub
biotinyl
label
antimous
ifnc
mab
dilut
spot
cytokineproduc
cell
count
express
number
spotform
cell
sfc
per
input
cell
sarscov
challeng
proteinvaccin
mice
intranas
challeng
sarscov
strain
tcid
previous
describ
challeng
mice
sacrif
day
postchalleng
lung
collect
virolog
test
viral
load
viral
replic
detect
viral
load
rna
copi
challeng
mous
lung
tissu
determin
quantit
reversetranscriptas
polymeras
chain
reaction
qrtpcr
accord
previous
describ
protocol
sarscov
replic
measur
use
cytopath
effect
cpe
base
assay
order
determin
titrat
viru
lung
tissu
sarscov
challeng
mice
viral
titer
calcul
describ
establish
stabl
cell
line
persist
express
recombin
rbd
protein
cell
transient
transfect
plasmid
encod
protein
purifi
protein
cell
cultur
exhibit
antigen
similar
recombin
express
cell
determin
elisa
western
blot
assay
data
shown
cultur
medium
cell
replac
fresh
select
medium
everi
day
resist
coloni
identifi
one
coloni
select
stabl
cell
b
fig
protein
express
reactiv
detect
elisa
detect
express
protein
cultur
supernat
stabl
cell
line
supernat
normal
cell
use
neg
control
control
data
present
mean
standard
error
se
three
parallel
well
b
express
protein
detect
western
blot
reactiv
rbd
mab
contain
conform
linear
epitop
one
mab
epitop
select
detect
label
reactiv
reactiv
high
reactiv
line
express
protein
adapt
cho
serumfre
medium
express
protein
monitor
elisa
use
rbdspecif
mab
shown
fig
continu
express
high
level
cultur
supernat
stabl
cell
line
least
six
month
suggest
stabl
cell
line
could
use
largequant
product
rbdbase
vaccin
need
protein
purifi
cell
cultur
media
analyz
sdspage
western
blot
use
panel
six
mab
specif
recogn
variou
conform
epitop
conf
ivi
one
mab
react
linear
epitop
rbd
fig
indic
express
protein
react
five
six
conform
epitopespecif
mab
one
linear
epitopespecif
mab
result
suggest
maintain
nativ
conform
authent
antigen
good
vaccin
antigen
first
abl
induc
humor
immun
respons
mainli
repres
induct
specif
antibodi
vaccin
individu
assess
balbc
mice
immun
purifi
protein
describ
materi
method
humor
immun
respons
neutral
activ
detect
vaccin
mous
sera
fig
indic
five
mice
vaccin
group
present
high
titer
rbdspecif
igg
antibodi
respons
sera
mean
endpoint
titer
reach
day
postlast
vaccin
rbdspecif
antibodi
significantli
neutral
infect
sar
pseudoviru
live
sarscov
vero
cell
respect
fig
result
indic
abl
induc
strong
humor
immun
respons
neutral
antibodi
proteinvaccin
mice
evalu
abil
protein
induc
cellular
immun
respons
splenocyt
collect
vaccin
mice
day
postlast
vaccin
stimul
respect
rbdspecif
peptid
peptid
purifi
rbd
protein
shown
fig
elicit
ctl
th
respons
repres
product
rel
higher
level
cell
ifncand
ctl
cell
stimul
ctl
peptid
th
peptid
respect
comparison
stronger
cell
respons
repres
induct
high
level
cell
could
observ
vaccin
mous
splenocyt
stimul
recombin
rbd
protein
addit
ifncexpress
cell
induc
rbd
protein
also
rel
higher
stimul
peptid
alon
fig
howev
undetect
level
cellular
immun
respons
found
splenocyt
pb
control
mice
overal
data
confirm
abil
protein
elicit
cellular
immun
respons
vaccin
mice
determin
protect
efficaci
protein
vaccin
mice
challeng
sarscov
lung
tissu
collect
day
postchalleng
detect
viral
load
rna
copi
viral
replic
log
tcid
sarscov
detect
mice
vaccin
protein
undetect
viral
rna
copi
challeng
mous
lung
contrast
high
level
viru
found
lung
tissu
five
pb
control
mice
viral
load
rang
rna
copieslg
lung
tissu
fig
consist
viru
replic
detect
three
five
vaccin
mice
challeng
sarscov
low
level
replic
viru
log
tcid
g
tissu
slightli
detect
limit
detect
lung
remain
two
mice
fig
suggest
could
induc
strong
immun
protect
major
vaccin
mice
sarscov
challeng
evalu
vivo
efficaci
vaccin
lethal
mous
model
warrent
mammalian
cell
express
system
rel
matur
eukaryot
system
express
recombin
protein
either
transient
stabli
express
recombin
antigen
promot
signal
synthesi
correctli
fold
secret
glycosyl
synthes
protein
recombin
protein
express
way
may
maintain
nativ
conform
good
antigen
immunogen
therefor
mammalian
cell
express
system
recent
use
express
varieti
heterolog
protein
includ
viral
structur
protein
bioactiv
peptid
specif
function
analysi
previous
shown
recombin
rbd
sarscov
protein
express
cell
could
induc
highli
potent
neutral
antibodi
respons
protect
immun
immun
mice
suggest
could
develop
effect
safe
sar
subunit
vaccin
prevent
sarscov
infect
howev
obtain
highli
express
rbd
protein
biolog
function
conveni
econom
way
sought
establish
stabl
cell
line
longterm
high
volum
product
recombin
rbd
therefor
cell
rather
cell
select
cell
abil
express
protein
interest
persist
high
level
base
rational
plasmid
transient
express
acid
residu
rbd
sarscov
protein
cell
construct
first
purifi
protein
character
function
confirm
stabl
cell
line
success
establish
demonstr
cell
line
could
highli
persist
express
protein
cultur
supernat
condit
medium
fig
purifi
protein
proven
exhibit
good
antigen
sinc
significantli
react
five
six
mab
recogn
conform
epitop
rbd
one
mab
specif
linear
rbd
epitop
fig
suggest
protein
maintain
intact
conform
analysi
immunogen
protein
mous
model
indic
express
protein
induc
potent
rbdspecif
antibodi
respons
neutral
antibodi
activ
fig
strong
cell
immun
respons
fig
compar
previouslydevelop
adenoassoci
virusexpress
rbd
rbdraav
vaccin
candid
protein
express
cell
could
induc
stronger
protect
immun
vaccin
mice
subsequ
sarscov
challeng
shown
undetect
viral
load
rna
copi
lung
challeng
mice
fig
although
viru
replic
detect
two
five
vaccin
mice
level
slightli
detect
limit
significantli
pb
control
fig
suggest
express
protein
could
induc
protect
sarscov
infect
major
vaccin
mice
consid
feasibl
high
express
recombin
rbd
protein
cell
larg
scale
rel
low
cost
studi
provid
suitabl
method
develop
subunit
sar
vaccin
prevent
futur
sar
outbreak
fig
protect
proteinvaccin
mice
sarscov
challeng
indic
five
mice
vaccin
control
group
respect
viral
load
detect
qrtpcr
express
rna
copieslg
lung
tissu
detect
limit
copieslg
tissu
b
sarscov
replic
determin
cpebas
assay
express
log
tcid
g
tissu
detect
limit
log
tcid
g
lung
tissu
